InvestorsHub Logo
Followers 40
Posts 5301
Boards Moderated 2
Alias Born 08/05/2002

Re: Willy post# 784

Sunday, 07/10/2011 8:03:08 PM

Sunday, July 10, 2011 8:03:08 PM

Post# of 9589
Willy,

See form 10k published in May.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Raw Materials
.............................
We have also completed the necessary testing to increase our production capabilities in order to meet the minimum distribution requirements under our exclusive distribution agreement.  Research has determined that our grow cycle, previously thought to be 30 days, can be shortened to 15 days with the same quality and bioactive results, resulting in the ability to double our production.
...............................
Manufacturing
We manufacture our ProAlgaZyme® product directly, using dedicated laboratory facilities on our own premises and qualified technical staff. We have leased a new facility that will include upgraded manufacturing capability, subject to completion of the build out of the facility which is ongoing.  After production, ProAlgaZyme® is currently bottled by a third party under our supervision to ensure product safety and integrity.  We believe that, subject to the availability of cash resources, manufacture of our product is scalable within a reasonable time to meet minimum distribution requirements of our exclusive sales agreement.   


Additional expansion of production is about MONEY ..... plain and simple. Again the increase in production has already been noted and discussed. Nothing new here. Available resources are going to the clinical testing cause it basically ALL flows from there.

Tis actually interesting. HEPIs never actually had any issues producing PAZ. And I don't expect there will be issues now.

Amigo Mike